You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Malignant Melanoma

Showing 51 - 75 of 7,605
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Malignant Melanoma Trial in Hangzhou (toripalimab, Temozolomide Injection)

Recruiting
  • Malignant Melanoma
  • Hangzhou, Zhejiang, China
    Department of Medical Onocology, First Affiliated Hospital of Zh
May 10, 2021

Adverse Effects Trial in Odense (Tablet: Samsung Galaxy Tab A)

Completed
  • Adverse Effects
  • Tablet: Samsung Galaxy Tab A
  • Odense, Denmark
    Odense University Hospital
Nov 7, 2021

Malignant Melanoma Trial in San Diego, Memphis, Houston (Peginterferon alfa-2b, Temozolomide, Recombinant interferon alfa-2b)

Active, not recruiting
Has Results
  • Malignant Melanoma
  • Peginterferon alfa-2b
  • +2 more
  • San Diego, California
  • +2 more
Apr 1, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Malignant Tumor in the CNS

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Scottsdale, Arizona
  • +2 more
Jan 4, 2023

The Gut Microbiome and Immune Checkpoint Inhibitor Therapy in

Recruiting
  • Non-Small-Cell Lung Carcinoma
  • +3 more
  • Checkpoint Inhibitor, Immune
  • Elizabethtown, Kentucky
    Baptist Health Clinical Research
Apr 25, 2022

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Los Angeles

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Magnetic Resonance Imaging using 7 Tesla MRI
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Nov 12, 2022

Reflectance Confocal Microscopy to Diagnose MM & LM

Completed
  • Melanoma (Skin)
  • Lentigo Maligna
  • In-vivo imaging
  • London, United Kingdom
    Skin Care Network Barnet Ltd
Nov 11, 2021

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Lung, Metastatic Melanoma Trial in Rochester

Not yet recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +4 more
  • Aerosol Sargramostim
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Jan 30, 2023

Metastasis From Malignant Melanoma of Skin (Diagnosis) Trial in Lausanne (FLASH therapy)

Recruiting
  • Metastasis From Malignant Melanoma of Skin (Diagnosis)
  • FLASH therapy
  • Lausanne, Vaud, Switzerland
    Centre Hospitalier Universitaire Vaudois (CHUV)
Aug 24, 2021

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (Azacitidine, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Oct 31, 2022

Malignant Melanoma, Lung Cancer, or Colorectal Cancer Trial in Suzhou (TAA06 injection)

Recruiting
  • Malignant Melanoma, Lung Cancer, or Colorectal Cancer
  • TAA06 injection
  • Suzhou, Jiangsu, China
    PersonGen BioTherapeutics(Suzhou) Co., Ltd.
Dec 29, 2021

Advanced Solid Tumor (Phase 1), Pancreatic Adenocarcinoma, Malignant Melanoma (Cutaneous) Trial in United States (IMM-1-104)

Recruiting
  • Advanced Solid Tumor (Phase 1)
  • +4 more
  • Duarte, California
  • +4 more
Feb 2, 2023

Unresectable, Recurrent or Metastatic Melanoma, Untreated Mucosal or Acral Lentiginous Melanoma Trial in China (MGD013)

Terminated
  • Unresectable, Recurrent or Metastatic Melanoma
  • Untreated Mucosal or Acral Lentiginous Melanoma
  • Beijing, Beijing, China
  • +12 more
Apr 12, 2022

Melanoma Trial in Seoul (regorafenib)

Recruiting
  • Melanoma
  • Seoul, Korea, Republic of
    Severance Hospital, Yonsei University Health System
Apr 1, 2021

Melanoma, Brain Metastases Trial in Canada (Dabrafenib, Trametinib)

Terminated
Has Results
  • Melanoma
  • Brain Metastases
  • Halifax, Nova Scotia, Canada
  • +5 more
Aug 18, 2021

Responsiveness in Oncology Patients Based on Host Response

Recruiting
  • Stage IV Non-small Cell Lung Cancer
  • +3 more
  • Plasma sample collection
  • Birmingham, Alabama
  • +40 more
Jan 31, 2023

Malignant Melanoma Trial in Herlev (Cyclophosphamide, Fludarabine Phosphate, Multiple Antigen Specific Endogenously derived T

Recruiting
  • Malignant Melanoma
  • Herlev, Denmark
    National Center for Cancer Immune Therapy (CCIT-DK)
Sep 14, 2021

PET Imaging of the Immune System Using Analog Probes

Completed
  • Malignant Melanoma
  • [18F] CFA
  • Los Angeles, California
    University of California, Los Angeles
Oct 8, 2021

Malignant Melanoma Stage III, Malignant Melanoma Stage IV Trial in Jette (TriMix-DC and ipilimumab)

Completed
  • Malignant Melanoma Stage III
  • Malignant Melanoma Stage IV
  • TriMix-DC and ipilimumab
  • Jette, Brabant, Belgium
    UZ Brussel
Mar 24, 2021

Malignant Melanoma Trial in Germany, Italy (4SC-202 in combination with Pembrolizumab)

Completed
  • Malignant Melanoma
  • 4SC-202 in combination with Pembrolizumab
  • Essen, Germany
  • +6 more
Feb 3, 2022

Melanoma, Malignant Melanoma, Stage IIIA Melanoma Trial in Orange (procedure, other, drug)

Completed
Has Results
  • Melanoma
  • +4 more
  • therapeutic conventional surgery
  • +3 more
  • Orange, California
    Chao Family Comprehensive Cancer Center
Dec 30, 2020

Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Malignant Tumor in the Brain, Metastatic Melanoma Trial in Columbus

Recruiting
  • Clinical Stage IV Cutaneous Melanoma AJCC v8
  • +3 more
  • Columbus, Ohio
    Ohio State University Comprehensive Cancer Center
Dec 28, 2022

Melanoma and Other Malignant Tumors of Skin, Metastatic Melanoma Trial in Houston (GSK2636771, Pembrolizumab)

Active, not recruiting
  • Melanoma and Other Malignant Neoplasms of Skin
  • Metastatic Melanoma
  • Houston, Texas
    University of Texas MD Anderson Cancer Center
Sep 22, 2022

Advanced Solid Tumor, Castration-Resistant Prostatic Cancer, Malignant Melanoma Trial in United States (MGC018, lorigerlimab)

Recruiting
  • Advanced Solid Tumor
  • +6 more
  • vobramitamab duocarmazine
  • lorigerlimab
  • Los Angeles, California
  • +7 more
Jan 10, 2023

Advanced Malignant Solid Tumor, Stage III Cutaneous Melanoma AJCC v7, Stage III Prostate Cancer AJCC v7 Trial in New Brunswick

Active, not recruiting
  • Advanced Malignant Solid Neoplasm
  • +9 more
  • New Brunswick, New Jersey
    Rutgers Cancer Institute of New Jersey
Jan 25, 2023